Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remifentanil Titration Techniques During FESS Under TIVA
NCT03389763Completed
- Sponsor
- Medical University of Silesia
- Start
- Jun 2016
- Primary completion
- Jan 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised trial of remifentanil in Endoscopic Sinus Surgery (FESS) (3 arms), sponsored by Medical University of Silesia. Primary endpoint: Blood loss postoperatively. Started Jun 2016; status: completed.
02
Drugs
remifentanil
03
Conditions
Endoscopic Sinus Surgery (FESS)
Beyond the preview
Go deeper on NCT03389763.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03389763.